Albert Assad
Incyte Corporation
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Albert Assad as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 21:29 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT06585774 · A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host DiseaseIncyte Corporation · recruiting · Chronic Graft-versus-host-disease · study director
- Ph3NCT04551066 · To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)Incyte Corporation · terminated · Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis · study director
- Ph3NCT04551053 · To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304)Incyte Corporation · terminated · Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis · study director
- Ph2NCT03123588 · Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)Incyte Corporation · terminated · MPN (Myeloproliferative Neoplasms) · study director
- Ph2NCT02723994 · A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic LeukemiaIncyte Corporation · completed · Leukemia · study director
- Ph2NCT02718300 · A Study of INCB050465 in Combination With Ruxolitinib in Subjects With MyelofibrosisIncyte Corporation · terminated · MPN (Myeloproliferative Neoplasms) · study director
- Ph2NCT02119676 · Study of Ruxolitinib in Colorectal Cancer PatientsIncyte Corporation · terminated · CRC (Colorectal Cancer) · study director
- Ph1/Ph2NCT01858883 · Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid TumorsIncyte Corporation · completed · Solid Tumors, Pancreatic Cancer · study director
- Ph2NCT01633372 · An Open Label Study of Itacitinib Administered Orally in Patients With MyelofibrosisIncyte Corporation · completed · MPN (Myeloproliferative Neoplasms) · study director
- Ph2NCT00726232 · Study to Determine the Safety and Efficacy of INCB018424 in Patients With Polycythemia Vera or Essential ThrombocythemiaIncyte Corporation · terminated · Myeloproliferative Neoplasm (MPN) · study director
Grants
NIH projects from RePORTER, fetched 2026-11-11 21:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 21:29 UTC. The ranking covers the 200 most relevant of 17 PubMed records, and a shared surname and initials can bring in a namesake. All 17 on PubMed
- Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma.J Clin Oncol · 2007202 citationsRCR 4.2
- Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis.Haematologica · 201795 citationsRCR 3.0
- 52 citationsRCR 1.9
- Clinical and radiographic evaluation of implant-retained mandibular overdentures with immediate loading.Implant Dent · 200739 citationsRCR 2.0
- A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab-Paclitaxel and Gemcitabine in Advanced Solid Tumors.Oncologist · 201939 citationsRCR 1.4
- Randomized, double-blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer.Cancer Med · 201839 citationsRCR 1.2
- Ingestion of colostrum from specific cows induces Bovine Neonatal Pancytopenia (BNP) in some calves.BMC Vet Res · 201134 citationsRCR 1.3
- Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases.Ann Rheum Dis · 202234 citationsRCR 1.9
- Comparison between mainly mucosa-supported and combined mucosa-implant-supported mandibular overdentures.Implant Dent · 200428 citationsRCR 1.6
- Phase 2 study of add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: final results.Blood Adv · 202418 citationsRCR 2.4